Sarcopenia and Related Factors in Patients With Multiple Sclerosis
NCT ID: NCT07116070
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2025-06-01
2026-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recent studies have revealed a high prevalence of sarcopenia in MS patients, which can have negative effects on physical performance, quality of life, and disease progression. Low muscle mass in MS patients can accelerate the loss of motor function and increase the level of disability. Additionally, nutritional deficiencies and low protein intake seen in MS patients are among the factors that accelerate muscle loss.
Studies examining the relationship between MS and sarcopenia in the literature emphasize the importance of early diagnosis and intervention to improve patients' quality of life and functional independence. Factors such as muscle strength, physical activity level, and nutritional status should be assessed to determine the risk of sarcopenia in MS patients.
This study was designed to determine the prevalence of sarcopenia in patients with Multiple Sclerosis (MS) and to examine the relationship between sarcopenia and fatigue, disability level (EDSS), nutritional status, and physical activity level.
In this context:
* The prevalence of sarcopenia in MS patients will be determined,
* The relationship between sarcopenia and muscle strength, physical performance, and body composition will be evaluated,
* The effects of nutrition and physical activity on sarcopenia in MS patients will be investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Relationship Between Fatigue and Physical Activity Level in Patients With Multiple Sclerosis
NCT03255460
3 Meter Backwards Walk Test and Multiple Sclerosis
NCT04004026
Investigation of the Effects of Selective Exercise Training in Multiple Sclerosis
NCT04853654
Muscle Fatigue in Patients With Multiple Sclerosis
NCT04548310
Efficiency of Different Exercise Approaches in Individuals Providing Primary Care to MS
NCT05896995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
One group (Observational Cohort)
MS patients (18 years and older) followed in the clinic.
Clinical Assessments
Participants will undergo the following assessments:
* Muscle strength: Handgrip strength test (using a digital dynamometer),
* Muscle mass: Bioelectrical impedance analysis (BIA) or DXA,
* Physical performance: 6-minute walk test, 5-repetition sit-to-stand test,
* Fatigue: Modified Fatigue Impact Scale (MFIS),
* Disability: EDSS,
* Nutritional status: Mini Nutritional Assessment (MNA),
* Physical activity: Godin Leisure-Time Exercise Questionnaire,
* Quality of life: MSQoL-54.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical Assessments
Participants will undergo the following assessments:
* Muscle strength: Handgrip strength test (using a digital dynamometer),
* Muscle mass: Bioelectrical impedance analysis (BIA) or DXA,
* Physical performance: 6-minute walk test, 5-repetition sit-to-stand test,
* Fatigue: Modified Fatigue Impact Scale (MFIS),
* Disability: EDSS,
* Nutritional status: Mini Nutritional Assessment (MNA),
* Physical activity: Godin Leisure-Time Exercise Questionnaire,
* Quality of life: MSQoL-54.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having been diagnosed with Multiple Sclerosis (confirmed by a neurologist),
* Being in a stable phase of the disease (having not had an attack in the last 3 months),
* Having preserved walking ability (EDSS score ≤6.5),
* Being able to give informed consent to participate in the study.
Exclusion Criteria
* Having developed significant muscle loss within the last 6 months due to use of corticosteroids or immunosuppressive therapy.
* Having systemic diseases that can cause muscle loss, such as cancer, rheumatic diseases, or severe metabolic disorders.
* Having undergone major surgery or a history of serious trauma within the last 3 months.
* Being pregnant or breastfeeding.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Selcuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Kaan ALTUNOK
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İsmail ÖZSOY, Assoc. Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Haluk GÜMÜŞ, Prof. Dr.
Role: STUDY_CHAIR
Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye
Gülşah ÖZSOY, Assist. Prof. Dr.
Role: STUDY_CHAIR
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Zehra KORKUT, Assist. Prof. Dr.
Role: STUDY_CHAIR
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Yasemin GEDİKLİ, Res. Asst.
Role: STUDY_CHAIR
Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye
Emel A ATAMAN AKTAŞ, Dr.
Role: STUDY_CHAIR
Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye
Omar E QUTOB, Dr.
Role: STUDY_CHAIR
Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Selcuk University Faculty of Medicine Hospital MS Life Center
Konya, Selcuklu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6.
Guigoz Y. The Mini Nutritional Assessment (MNA) review of the literature--What does it tell us? J Nutr Health Aging. 2006 Nov-Dec;10(6):466-85; discussion 485-7.
Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995 Jun;4(3):187-206. doi: 10.1007/BF02260859.
Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, Karabudak R. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007 Mar;30(1):81-5. doi: 10.1097/MRR.0b013e3280146ec4.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444-52. doi: 10.1212/wnl.33.11.1444.
Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008 Apr;14(3):383-90. doi: 10.1177/1352458507082607. Epub 2007 Oct 17.
Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011 Jul;40(4):423-9. doi: 10.1093/ageing/afr051. Epub 2011 May 30.
Carvalho BM, Silva RSC, Lima VVM, Almondes KGS, Rodrigues FNS, D'Almeida JAC, Melo MLP. Excess weight increases the risk of sarcopenia in patients with multiple sclerosis. Mult Scler Relat Disord. 2023 Nov;79:105049. doi: 10.1016/j.msard.2023.105049. Epub 2023 Oct 8.
Gaemelke T, Pedersen IS, Dalgas U, Hvid LG. Sarcopenia in older people with multiple sclerosis: A cross-sectional study. Mult Scler Relat Disord. 2025 Jan;93:106190. doi: 10.1016/j.msard.2024.106190. Epub 2024 Nov 25.
Yuksel H, Balaban M, Tan OO, Mungan S. Sarcopenia in patients with multiple sclerosis. Mult Scler Relat Disord. 2022 Feb;58:103471. doi: 10.1016/j.msard.2021.103471. Epub 2021 Dec 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SelcukU_PT_MS_SARCOPENIA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.